Menon, R., Otto, E. A., Sealfon, R., Nair, V., Wong, A. K., Theesfeld, C. L., Chen, X., Wang, Y., Boppana, A. S., Luo, J., Yang, Y., Kasson, P. M., Schaub, J. A., Berthier, C. C., Eddy, S., Lienczewski, C. C., Godfrey, B., Dagenais, S. L., Sohaney, R., Hartman, J., Fermin, D., Subramanian, L., Looker, H.…
Read MoreHanna, S. J., Powell, W. E., Long, A. E., Robinson, E. J. S., Davies, J., Megson, C., Howell, A., Jones, T. J., Ladell, K., Price, D. A., Dayan, C. M., Williams, A. J. K., Gillespie, K. M. and Wong, F. S. Slow progressors to type 1 diabetes lose islet autoantibodies over time, have few islet…
Read MoreKolundzic, N., Khurana, P., Devito, L., Jeriha, J., Marx, J., Hobbs, C., Wong, X. F. C. C., Common, J. E., Liovic, M., Dubrac, S., Gruber, R., Schmuth, M., Mauro, T. M., Ilic, D. Induced pluripotent stem cell line heterozygous for p.R501X mutation in filaggrin: KCLi003-A. Stem Cell Research. 2019; 39, 101527. doi:10.1016/j.scr.2019.101527
Read MoreSharma, R., Khristov, V., Rising, A., Jha, B. S., Dejene, R., Hotaling, N., Li, Y., Stoddard, J., Stankewicz, C., Wan, Q., Zhang, C., Campos, M. M., Miyagishima, K. J., McGaughey, D., Villasmil, R., Mattapallil, M., Stanzel, B., Qian, H., Wong, W., Chase, L., Charles, S., McGill, T., Miller, S., Maminishkis, A., Amaral, J., Bharti, K.…
Read MoreTechnology Transfer and Process Development for an Autologous Cell Therapy Against Multiple Sclerosis
Read More